reviewJAMA PsychiatryMar 1, 2017Closed access

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

Yale University · Mayo Clinic · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

IMPORTANCE: Several studies now provide evidence of ketamine hydrochloride's ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. Despite the relatively small sample sizes, lack of longer-term data on efficacy, and limited data on safety provided by these studies, they have led to increased use of ketamine as an off-label treatment for mood and other psychiatric disorders. OBSERVATIONS: This review and consensus statement provides a general overview of the data on the use of ketamine for the treatment of mood disorders and highlights the limitations of the existing knowledge. While ketamine may be beneficial to some…

No related works found for this paper.